MarketScreener Homepage > Equities > TSX VENTURE EXCHANGE > ImmunoPrecise Antibodies Ltd. IPA CA45257F2008

Report

Delayed TSX VENTURE EXCHANGE - 01/15 03:59:59 pm
18.35	CAD		-2.45%

01/06

IMMUNOPRECISE ANTIBODIES : Announces Grant of Stock Options

01/06

IMMUNOPRECISE ANTIBODIES : to Participate in January Conferences

2020

Upcoming events on IMMUNOPRECISE ANTIBODIES LTD.

03/31/21		Q3 2021 Ergebnisveröffentlichung (geplant)
10/05/21		Q1 2022 Ergebnisveröffentlichung (geplant)
12/23/21		Erstes Halbjahr 2022 Ergebnisveröffentlichung (geplant)
03/30/22		Q3 2022 Ergebnisveröffentlichung (geplant)

Past events on IMMUNOPRECISE ANTIBODIES LTD.

01/11/21 \| 12:00pm		H.C. Wainwright Bioconnect Conference
12/21/20 \| 02:12pm		Erstes Halbjahr 2021 Ergebnisveröffentlichung
11/20/20 \| 07:00pm		Jahreshauptversammlung
10/01/20 \| 05:00pm		Gravitas Healthcare Investor Day

Upcoming sector events for IMMUNOPRECISE ANTIBODIES LTD.

01/19/21		BRIDGEBIO PHARMA, INC. : Extraordinary Shareholders Meeting - M&A Vote
01/22/21		ABBVIE INC. : FY 2020 Earnings Release (Projected)
01/22/21 \| 01:00am		WALVAX BIOTECHNOLOGY CO., LTD. : Extraordinary Shareholders Meeting
01/22/21 \| 02:30am		BETTA PHARMACEUTICALS CO., LTD. : Extraordinary Shareholders Meeting

Past sector events for IMMUNOPRECISE ANTIBODIES LTD.

01/15/21		VIFOR PHARMA AG : Baader Swiss Equities Conference
01/14/21 \| 02:00pm		ABCAM PLC : JP Morgan Healthcare Conference
01/14/21		ROCHE HOLDING AG : Octavian Seminar
01/14/21		VIFOR PHARMA AG : Octavian Seminar

Annual publications

Annual results		2018	2019	2020	2021 (e)
Sales M CAD	Released Forecast Spread	5,44	10,9 11,7 -6,6%	14,1 14,0 0,37%	20,4
Operating income (EBITDA) M CAD	Released Forecast Spread	-4,65	-3,90 -1,70 -129%	0,05 0,10 -48%	3,13
Operating profit (EBIT) M CAD	Released Forecast Spread			-4,55 -3,28 -39%	-4,80
Pre-Tax Profit (EBT) M CAD	Released Forecast Spread			-5,29 -4,10 -29%	-2,35
Net income M CAD	Released Forecast Spread			-4,95 -4,29 -15%	-2,59
EPS CAD	Released Forecast Spread	-0,55		-0,35 -0,30 -17%	-0,14
Announcement Date		08/28/2018	08/28/2019	08/28/2020

Quarterly publications

Previous period

Next period

Quarterly results		2019 Q2	2019 Q3	2019 Q4	2020 Q4	2021 Q1	2021 Q2	2021 Q3 (e)	2021 Q4 (e)	2022 Q1 (e)	2022 Q2 (e)	2022 Q3 (e)
Sales M CAD	Released Forecast Spread	2,72 3,55 -23%	2,70 2,80 -3,7%	2,64 3,40 -22%	4,15 4,09 1,3%	3,76 4,48 -16%	4,75 4,74 0,23%	5,85	6,01	6,02	6,18	6,43
Operating income (EBITDA) M CAD	Released Forecast Spread	-0,74 -0,30 -146%	-0,46 -0,28 -64%		0,03 0,08 -59%	0,93 0,09 940%	0,80 0,69 14%	1,05	0,36	0,52	0,51	1,01
Operating profit (EBIT) M CAD	Released Forecast Spread				-1,57 -0,29 -440%	-0,97 -0,29 -231%	-2,27 -0,38 -497%	-0,44	-1,13	-0,95	-0,96	-0,46
Pre-Tax Profit (EBT) M CAD	Released Forecast Spread	-1,33 -1,10 -21%			-1,48 -0,29 -412%	-0,37 -0,29 -25%	-0,41 -0,38 -6,6%	-0,44	-1,13	-0,96	-0,96	-0,47
Net income M CAD	Released Forecast Spread	-1,49 -1,10 -35%			-0,95 -0,29 -226%	-0,55 -0,29 -87%	-0,46 -0,38 -21%	-0,44	-1,13	-0,96	-0,96	-0,47
EPS CAD	Released Forecast Spread	-0,10 -0,10 0,00%			-0,05	-0,05	-0,03 -0,02 -50%	-0,03	-0,07	-0,06	-0,06	-0,03
Announcement Date		12/28/2018	03/27/2019	08/28/2019	08/28/2020	09/29/2020	12/21/2020

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise